Halozyme Therapeutics (HALO) Loss Anticipated to Narrow

Halozyme Therapeutics is expected to book a narrower loss than a year ago when it reports third quarter earnings on Friday, November 8, 2013 with analysts expecting a loss of 16 cents per share, up from a loss of 18 cents per share a year ago.